Mosliciguat not checked

Pulmovant, Inc.

FollowEvery change as it happens, and a Monday email
Stage
 
Next date
Phase 2 trial completes
Trials
3 active
4 in total · 2 in the EU
Targets
—
None known yet

What this is

How it works
Boosts a chemical signal (cGMP) that relaxes blood vessels and eases strain on the heart.-ciguat: guanylate cyclase activators and stimulators WHO name stem
Tested for
Pulmonary Hypertension (3 trials), Vascular Diseases (3 trials), Cardiovascular Diseases (3 trials), Fibrosis (3 trials), Interstitial Lung Disease (2 trials), Lung Diseases (2 trials), Interstitial Lung Disease (ILD)
Main trialPhase 3
“A Phase 3, Multicenter, Randomized, Double-Blind Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Inhaled Mosliciguat in Participants with Pulmonary Hypertension Associated with Interstitial Lung Disease”In the company’s words, NCT07816185 on ClinicalTrials.gov

Other drugs for Pulmonary Hypertension

All 29 drugs for Pulmonary Hypertension

Coming up2

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials4

TrialPhaseCompletesWhat it tests
Phase 3Recruiting 28 Jan 2029 A Phase 3 Trial of Inhaled Mosliciguat in PH-ILD (PHrontier)
Phase 2Active, not recruiting 26 May 2026 A Study of Mosliciguat in PH-ILD
Phase 2Recruiting Dec 2026 A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD
Phase 1Completed 30 Jun 2025 A Phase 1 Study of Mosliciguat in Healthy, Adult Males
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow Mosliciguat

Following is part of Solo: you see every change to Mosliciguat the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in